These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7864266)

  • 1. Mood, major depression, and fluoxetine response in cigarette smokers.
    Dalack GW; Glassman AH; Rivelli S; Covey L; Stetner F
    Am J Psychiatry; 1995 Mar; 152(3):398-403. PubMed ID: 7864266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of major depressive disorder during smoking-cessation treatment.
    Borrelli B; Niaura R; Keuthen NJ; Goldstein MG; DePue JD; Murphy C; Abrams DB
    J Clin Psychiatry; 1996 Nov; 57(11):534-8. PubMed ID: 8968303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia.
    Hellerstein DJ; Yanowitch P; Rosenthal J; Samstag LW; Maurer M; Kasch K; Burrows L; Poster M; Cantillon M; Winston A
    Am J Psychiatry; 1993 Aug; 150(8):1169-75. PubMed ID: 8328559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
    Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
    J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder.
    Lam RW; Gorman CP; Michalon M; Steiner M; Levitt AJ; Corral MR; Watson GD; Morehouse RL; Tam W; Joffe RT
    Am J Psychiatry; 1995 Dec; 152(12):1765-70. PubMed ID: 8526243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group.
    Zisook S; Peterkin J; Goggin KJ; Sledge P; Atkinson JH; Grant I
    J Clin Psychiatry; 1998 May; 59(5):217-24. PubMed ID: 9632030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-cessation depressive mood predicts failure to quit smoking: the role of coping and personality traits.
    Berlin I; Covey LS
    Addiction; 2006 Dec; 101(12):1814-21. PubMed ID: 17156181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of fluoxetine on positive and negative affect in a clinic-based smoking cessation trial.
    Cook JW; Spring B; McChargue DE; Borrelli B; Hitsman B; Niaura R; Keuthen NJ; Kristeller J
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):153-9. PubMed ID: 14727000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidity, smoking behavior and treatment outcome.
    Keuthen NJ; Niaura RS; Borrelli B; Goldstein M; DePue J; Murphy C; Gastfriend D; Reiter SR; Abrams D
    Psychother Psychosom; 2000; 69(5):244-50. PubMed ID: 10965289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind fluoxetine in depressed alcoholic smokers.
    Cornelius JR; Salloum IM; Ehler JG; Jarrett PJ; Cornelius MD; Black A; Perel JM; Thase ME
    Psychopharmacol Bull; 1997; 33(1):165-70. PubMed ID: 9133770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of major depression after treatment for smoking cessation.
    Tsoh JY; Humfleet GL; Muñoz RF; Reus VI; Hartz DT; Hall SM
    Am J Psychiatry; 2000 Mar; 157(3):368-74. PubMed ID: 10698811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine versus trazodone in the treatment of outpatients with major depression.
    Debus JR; Rush AJ; Himmel C; Tyler D; Polatin P; Weissenburger J
    J Clin Psychiatry; 1988 Nov; 49(11):422-6. PubMed ID: 3053668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression.
    Cox LS; Patten CA; Niaura RS; Decker PA; Rigotti N; Sachs DP; Buist AS; Hurt RD
    J Gen Intern Med; 2004 Aug; 19(8):828-34. PubMed ID: 15242467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial.
    Rabkin JG; Wagner GJ; Rabkin R
    Am J Psychiatry; 1999 Jan; 156(1):101-7. PubMed ID: 9892304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern analysis of antidepressant response to fluoxetine.
    Fieve RR; Goodnick PJ; Peselow ED; Barouche F; Schlegel A
    J Clin Psychiatry; 1986 Nov; 47(11):560-2. PubMed ID: 3533909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Depression and smoking].
    Aubin HJ; Tilikete S; Barrucand D
    Encephale; 1996; 22(1):17-22. PubMed ID: 8681871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.